BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36841463)

  • 1. Pain and ease of insertion of three different intrauterine devices in Brazilian adolescents: A participant-blinded randomized trial.
    Anjos FCQS; Marcelino AC; Espejo-Arce X; Pereira PDC; Barbosa PF; Juliato CT; Bahamondes L
    Contraception; 2023 Jun; 122():109997. PubMed ID: 36841463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Assessment of 3 Intrauterine Devices in Adolescent Girls: A Randomized Clinical Trial.
    Anjos FCQS; Marcelino AC; Espejo-Arce X; Pereira PDC; Barbosa PF; Juliato CT; Bahamondes L
    J Pediatr Adolesc Gynecol; 2024 Apr; 37(2):165-170. PubMed ID: 38113970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
    Suvisaari J; Lähteenmäki P
    Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.
    Turok DK; Gero A; Simmons RG; Kaiser JE; Stoddard GJ; Sexsmith CD; Gawron LM; Sanders JN
    N Engl J Med; 2021 Jan; 384(4):335-344. PubMed ID: 33503342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding profile satisfaction and pain and ease of placement with levonorgestrel 19.5 mg IUD: findings from the Kyleena
    Donders G; Kopp Kallner H; Hauck B; Bauerfeind A; Frenz AK; Zvolanek M; Stovall DW
    Eur J Contracept Reprod Health Care; 2023 Feb; 28(1):1-9. PubMed ID: 36342694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of pain and ease of intrauterine device placement according to type of device, parity, and mode of delivery.
    Lopes-Garcia EA; Carmona EV; Monteiro I; Bahamondes L
    Eur J Contracept Reprod Health Care; 2023 Jun; 28(3):163-167. PubMed ID: 36961099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in intrauterine devices.
    Farr G
    Netw Res Triangle Park N C; 1991 Sep; 12(2):9. PubMed ID: 12284281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate postabortal insertion of intrauterine devices.
    Grimes DA; Lopez LM; Schulz KF; Stanwood NL
    Cochrane Database Syst Rev; 2010 Jun; (6):CD001777. PubMed ID: 20556754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR).
    Sivin I; Stern J
    Fertil Steril; 1994 Jan; 61(1):70-7. PubMed ID: 8293847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications and continuation of intrauterine device use among commercially insured teenagers.
    Berenson AB; Tan A; Hirth JM; Wilkinson GS
    Obstet Gynecol; 2013 May; 121(5):951-958. PubMed ID: 23635730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
    Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J
    Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
    Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
    Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device.
    Hinz EK; Murthy A; Wang B; Ryan N; Ades V
    Contraception; 2019 Aug; 100(2):101-105. PubMed ID: 31108053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.